Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicentre Observational Follow-up Study of PegIFN Treatment Sustained Response in Nucleoside Experienced Patients With Chronic Hepatitis B (the OCEAN Study)

NCT03358108 is registered in ClinicalTrials.gov with Qin Ning as lead sponsor.

NCT NCT03358108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03358108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicentre Observational Follow-up Study of PegIFN Treatment Sustained Response in Nucleoside Experienced Patients With Chronic Hepatitis B (the OCEAN Study)
Lead sponsor
Qin Ning
Phase
Observational
Overall status
Unknown status
Start date
February 27, 2018
Completion date
December 1, 2022
Enrollment
1,600 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, chronic